Influence of the pharmacological modification of gastric emptying on lactose digestion and gastrointestinal symptoms

Alimentary Pharmacology and Therapeutics

Volumn 13, Issue 1, 1999, Pages 81-86

  Peuhkuri, K ^a   Vapaatalo, H ^b   Nevala, R ^b   Korpela, R ^a  

^a FOUNDATION FOR NUTRITION RESEARCH   (Finland)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

CARMINIC ACID; GALACTOSE; GLUCOSE; HYDROGEN; LACTOSE; METOCLOPRAMIDE; PROPANTHELINE BROMIDE;

ADULT; AREA UNDER THE CURVE; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DIGESTION; DOUBLE BLIND PROCEDURE; DRUG EFFECT; FEMALE; GASTROINTESTINAL SYMPTOM; GASTROINTESTINAL TRANSIT; GLUCOSE BLOOD LEVEL; HUMAN; HYDROGEN BREATH TEST; LACTOSE INTOLERANCE; LACTOSE TOLERANCE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; STOMACH EMPTYING; URINARY EXCRETION;

ADULT; ANTIEMETICS; BLOOD GLUCOSE; BREATH TESTS; CROSS-OVER STUDIES; DOUBLE-BLIND METHOD; FEMALE; GALACTOSE; GASTRIC EMPTYING; HUMANS; HYDROGEN; LACTOSE INTOLERANCE; LACTOSE TOLERANCE TEST; METOCLOPRAMIDE; MIDDLE AGED; MUSCARINIC ANTAGONISTS; PROPANTHELINE; SEVERITY OF ILLNESS INDEX; TIME FACTORS;

EID: 0032934681     PISSN: 02692813     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2036.1999.00450.x     Document Type: Article

References (16)

1. 1 Sahi T. Lactose malabsorption in Finnish-speaking and Swedish-speaking populations in Finland. Scand J Gastroenterol 1974; 9: 303-8.
2. 2 Sahi T. Genetics and epidemiology of adult-type hypolactasia. Scand J Gastroenterol 1994; 29(Suppl. 202): 7-20.
3. 3 Villako K, Maaroos H. Clinical picture of hypolactasia and lactose intolerance. Scand J Gastroenterol 1994; 29(Suppl. 202): 36-54.
4. 4 O'Brien JD, Thompson DG, Mcintyre A. et al. Effect of codeine and loperamide on upper intestinal transit and absorption in normal subjects and patients with post vagotomy diarrhoea. Gut 1988; 29: 312-18.
5. 5 Hurwitz A, Robinson RG, Herrin WF. Prolongation of gastric emptying by oral propantheline. Clin Pharm Ther 1977; 22: 206-10.
6. 6 Dollery C (ed). Therapeutic Drugs, Vol. 2. Beccles and London: Churchill Livingstone, 1991: M149-52; 266-8.
7. 7 Solomons NW, Guerrero AM, Torun B. Dietary manipulation of postprandial colonic lactose fermentation: Effect of solid foods in a meal. Am J Clin Nutr 1985; 41: 199-208.
8. 8 Martini MC, Savaiano DA. Reduced intolerance symptoms from lactose consumed during a meal. Am J Clin Nutr 1988; 47: 57-60.
9. 9 Szilagyi A, Salomon R, Scideman E. Influence of loperamide on lactose handling and oro-caecal transit time. Aliment Pharmacol Ther 1996; 10: 765-70.
10. 2) concentrations to quantify carbohydrate malabsorption by means of lactulose standards. Gut 1990; 31: 37-42.
11. 11 Teuri U. Hiilihydraattien aiheuttamat suolisto-oireet hypolaktaasikoilla (in Finnish) (Gastrointestinal symptoms caused by carbohydrates in lactose maldigesters). Master's Thesis, University of Helsinki, 1997.
12. 2 for diagnosing hypolactasia. Scand J Clin Lab Invest 1998; 58: 217-24.
13. 13C)-glucose oxidation during exercise. Int J Sports Med 1996; 17: 165-9.
14. 14 Peuhkuri K, Korpela R. Mykkänen H. Fibre-enriched juice in the treatment of constipation in the elderly. Näringsforskning 1994; S29: A11(Abstract).
15. 15 Degen LP, Philips SF. Variability of oro-caecal transit in healthy women and men. Gut 1996; 39: 299-305.
16. 16 Arola H. Diagnosis of hypolactasia and lactose malabsorption. Scand J Gastroenterol 1994; 29(Suppl. 202): 26-35.